Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Last updated: June 30, 2020
Sponsor: Institut Paoli-Calmettes
Overall Status: Active - Recruiting

Phase

N/A

Condition

Ovarian Cysts

Treatment

N/A

Clinical Study ID

NCT03667417
GENEPSO-IPC 2018-031
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Eligibility Criteria

Inclusion

  1. Woman or man, with or without cancer, carrying a deleterious BRCA1/BRCA2 mutation,aged 18 years and over.

  2. Woman with or without breast cancer or ovarian cancer at baseline.

  3. Man with or without breast cancer at baseline.

  4. Signed consent to participation

  5. Affiliation to a social security regimen, or beneficiary of such a regimen.

Exclusion

Exclusion Criteria:

  1. A person of legal age subject to a legal protection measure, or unable to expressconsent.

  2. Impossibility to submit to the follow-up of the test for geographical, social orpsychological reasons

Study Design

Total Participants: 5000
Study Start date:
October 15, 1999
Estimated Completion Date:
October 15, 2028

Study Description

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Connect with a study center

  • Institut Paoli-Calmettes

    Marseille, 13009
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.